Kam Lawrence’s Fennec Pharmaceuticals FENC Stock Holding History

Kam Lawrence’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5.42M	Buy	+834,689	New	+$4.48M	5.56%	5

Other funds holding FENC

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Hartford Financial Management Hartford, Connecticut $392M AUM 21.9% 1-Year Est. Return

Kam Lawrence's FENC Position: Q4 2019 in Review

Kam Lawrence opened a new position in Fennec Pharmaceuticals (FENC) in Q4 2019: 834,689 shares worth $5.42M. The stake represents 5.56% of the portfolio and ranks #5 among its holdings.

31 funds tracked by Wall St. Rank hold FENC as of Q4 2019.

Kam Lawrence held 834,689 shares of Fennec Pharmaceuticals worth $5.42M as of Q4 2019.
Fennec Pharmaceuticals was a new Kam Lawrence position in Q4 2019.
Fennec Pharmaceuticals made up 5.56% of Kam Lawrence's portfolio in Q4 2019, its #5 holding.
31 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2019.

Based on Kam Lawrence's 13F filing for Q4 2019, filed 13 Feb 2020.